Диссертация (1174369), страница 24
Текст из файла (страница 24)
- 2000. -Vol.899. - P. 191-208.143294. Steinberg, D. Oxidative modifications of LDL and atherogenesis/ D. Steinberg//Circulation. - 1997. - P. 95, 162295. Stocker, R. Endogenous antioxidant defences in human blood plasma. In: Sies H.ed. Oxidative stress: oxidants and antioxidants/R. Stocker, B. Frei// London. AcademicPress. - 1991. - P.213-243.296. Storch, A. S. Methods of Endothelial Function Assessment: Description andApplications/ A.S.
Storch, J.D. de Mattos, R. Alves, I. dos S. Galdino, H.N.M. Rocha//Int. J. Cardiovasc Sci. – 2017. -. 30(3). - P. 262-273.297. Suganya, N. Reversibility of endothelial dysfunction in diabetes: role ofpolyphenols/ N. Suganya, E. Bhakkiyalakshmi, DV. Sarada, KM. Ramkumar//Br. J.Nutr.– 2016 - 116(2) – P. 223-246.298. Sutton-Tyrrell, K.
Prediction of carotid stenosis in older adults with and withoutisolated systolic hypertension/ K. Sutton-Tyrrell, I. Alcorn, S. Wolfson et al.// Stroke. 1987. - № 18. -P. 817-22.299. Taddei, S. Mechanisms of endothelial dysfunction: clinical significance and preventive non-pharmacological therapeutic strategies/ S.
Taddei, L. Ghiadoni, A. Virdis,D. Versari, A. Salvetti// Curr. Pharm. Des. - 2003. - 9. - P. 2385–2402.300. Tanaka, H. Carotid atherosclerosis and silent cerebral infarction in patients withcoronary atherosclerosis/ H. Tanaka, M. Ishida, M. Nishino et al.// J. Jpn. Coll. Angiol.- 1991. -№ 31. P. 819-824.301. Tak, W.W. Endothelial dysfunction: the common consequence in diabetes andhypertension / W.W. Tak et al. // J. Cardiovasc. Pharmacol. - 2010. - Vol.
55. - P. 300307.302. Teixeira, B.C. Inflammatory markers, endothelial function and cardiovascularrisk/ B.C. Teixeira, A.L. Lopes, R.C.O. Macedo, C.S. Correa, T.R. Ramis, J. L.Ribeiro, A.J. Reischak-Oliveira// Vasc. Bras. - 2014. -132.- P. 108-115303. Timsit, S. Early clinical differentation of cerebral Infarction from severeatherosclerjtic stenosis and cardioembolizm/ S. Timsit, R. Sacco, J. Mohr et al.// Stroke.- 1992. - Vol.23(4). -P.
486-491.304. Thalhammer, C. Endothelial cell dysfunction and arterial wall hypertrophy are144associated with disturbed carbohydrate metabolism in patients at risk for cardiovasculardisease / C. Thalhammer, B. Balzuweit, A. Busjahn, С. Walter, F.C. Luft, H. Haller //Arteriosclerosis, thrombosis, and vascular biology. - 1999.
- Vol. 19(5). - P. 1173-1179.305. The European Carotid Surgery Trialists Collaborative Group.Screeningand carotid endarterectomy have been advocated for asymptomatic carotid stenosis /The European Carotid Surgery Trialists Collaborative Group // Lancet. - 1995. -V. 345.-P.209-212.306. Thomas, N. Role of oxidative carbonylation in protein/ N. Thomas// The EMBOJournal.
-2005. -№ 24. - P. 1311–1317.307. Uehara, Т. Asymptomatic occlusive lesion of carotid and intracranial arteries inJapanese patients with ischemic heart desease/ T. Uehara, M. Tabuchi, T. Hayashi etal.// Stroke. - 1996. - № 27. - P. 393-397.308. Urbinati, S.Frequency of silent coronary disease in patients with cerebralischemia undergoing carotid endareterectomy /S.
Urbinati, G. Di Pasquale, A. Andreoliet al.// Am. J. Cardiol. - 1992. - Vol. 69(14). - P. 1166-1170.309. Varona, J.F. Soluble ICAM 1 and VCAM 1 Blood Levels Alert on SubclinicalAtherosclerosis in Non Smokers with Asymptomatic Metabolic Syndrome/JF. Varona,R. Ortiz-Regalón, I. Sánchez-Vera, B. López-Melgar, C. García-Durango, JM.Castellano Vázquez, J. Solís, L. Fernández-Friera, F. Vidal-Vanaclocha.//Arch MedRes. - 2019.
- 50(2). P. 20-28.310. Verma, S. Endothelial Function Testing as a Biomarker of Vascular Disease/ S.Verma, M.R. Buchanan, T.J. Anderson// Circulation. - 2003. - Vol. 108. - P. 2054—2059.311. Verma, S. Fundamentals of endothelial function for the clinical cardiologist / S.Verma, T.J.
Anderson // Circulation. - 2002. - Vol.105.- P. 546-549.312. Versari, D. Endothelial dysfunction as a target for prevention of cardiovasculardisease / D. Versari et al. // Diabetes Care. - 2009. - Vol. 32. - P. 314-321.313. Wardlaw, J.M. Lacunar stroke is associated with diffuse blood-brain barrierdysfunction/ J. M. Wardlaw, F. Doubal, P. Armitage, F. Chappell, T. Carpenter, S.Muñoz Maniega, A.
Farrall, C. Sudlow, M. Dennis, B. Dhillon// Ann Neurol. - 2009. -145Vol.65. - P. 194-202.314. Watson, B.D. Ischemia in rat brain/ B.D.Watson, R. Busto, W.Y. Goldberg et al.//J.Neurochem. - 1984. - Vol. 42 - P. 268 – 275.315. Wells, P. G. Oxidative stress in developmental origins of disease: teratogenesis,neurodevelopmental deficits, and cancer/ P.G.
Wells, G. P. McCallum, C. S. Chen et al.// Toxicol. Sci. – 2009. – Vol.108(1). – P. 4–18.316. Wilkinson, I.B. Cholesterol, endothelial function and cardiovascular disease / I.B.Wilkinson, J.R. Cockcroft // Curr. Opin. Lipidol. - 1998. - Vol. 9(3). - P. 237-242.317. Wiseman, S. Blood Markers of Coagulation, Fibrinolysis, EndothelialDysfunction and Inflammation in Lacunar Stroke versus Non-Lacunar Stroke and NonStroke: Systematic Review and Meta-Analysis/ S. Wisema, F. Marlborough, D. FergusDoubal, J.
Webb, J. Wardlaw// Cerebrovasc. Dis. - 2014. - P. 64–75.318. Yang, Z. Recent advances in understanding endothelial dysfunction inatherosclerosis / Z. Yang, X.F. Ming // Clinical medicine and research. – 2006. – Vol.4,№1. – P. 53-65.319. Young, B. An analysis of perioperative surgical mortality and morbidity in theasymptomatic carotid atherosclerosis study/B. Young, W.S.
Moore, J.T. Robertson et.al / Stroke. 1996. - Vol. 27.- P. 2216-2224320. Zuzeik, M. Echogenic carotid plaques are associated with aortic arterial stiffnessin subjects with subclinical carotid atherosclerosis / M. Zuzeik, J. Bureau, M. Temmaret al. // Hypertension. 2003. - Vol.41, N3. - P.519-527..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
